Update on solar power purchase agreement and acquisition upto 26% stake in Swarnaakshu Solar Power Private Limited.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has informed exchanges that its plan to acquire up to 26% stake in Swarnaakshu Solar Power Private Limited, along with entering a captive solar power purchase agreement, will be delayed. The original deadline of March 31, 2026 has been pushed to on or before June 30, 2026. The reason for the delay is pending approval from the concerned state government for setting up the captive solar power plant. The investment amount and structure have not been disclosed in this update.
This is a minor, procedural update with no material financial impact — it is a 3-month delay in a non-core captive power investment, not a cancellation. Shareholders are unlikely to see any meaningful change in stock price or business outlook from this.